參考文獻(xiàn)/References:
[1] 梁文娜,李西海,李燦東,等.骨免疫與絕經(jīng)后骨質(zhì)疏松婦女骨重建失衡[J].國際骨科學(xué)雜志,2012,33(2):103-105.
[2] Somjen D,Katzburg S,Sharon O,et al.The effects of estrogen receptors α- and β-specific agonists and
antagonists on cell proliferation and energy metabolism in human bone cell line[J].J Cell Biochem,2011,112
(2):625-632.
[3] 粱文娜,葉蕻芝,廖凌虹,等.Ⅰ型膠原蛋白對骨礦化機(jī)制的影響[J].中國老年學(xué)雜志,2012,32(17):3840-3842.
[4] Li Y,Liang W,Li X,et al.Effect of serum from postmenopausal women with osteoporosis exhibiting the
Kidney-Yang deficiency pattern on bone formation in an hFOB 1.19 human osteoblastic cell line[J].Exp Ther
Med,2015,10(3):1089-1095.
[5] Jabbar S,Drury J,Fordham J,et al.Osteoprotegerin,RANKL and bone turnover in postmenopausal osteoporosis
[J].Osteoporosis International,2009,20(4):S271.
[6] Chen X,Talati M,Fessel JP,et al.Estrogen metabolite 16α-Hydroxyestrone exacerbates bone morphogenetic
protein receptor typeII-associated pulmonary arterial hypertension through microRNA-29-mediated modulation of
cellular metabolism[J].Circulation,2016,133(1):82-97.
[7] Liang W,Li X,Li Y,et al.Tongue coating microbiome regulates the changes in tongue texture and coating in
patients with post-menopausal osteoporosis of Gan-shen deficiency syndrome type[J].Int J Mol Med,2013,32
(5):1069-1076.
[8] Sugiya N,Nakashima A,Takasugi N,et al.Endogenous estrogen May prevent bone loss in postmenopausal
hemodialysis patients throughout Life[J].Osteoporos Int,2011,22(5):1573-1579.
[9] Zheng XK,Zhang X,Wang XL,et al.Effect of estrogen-like effective part of selaginella tarmariscina on bone
metabolism[J].Zhong Yao Cai,2014,37(10):1825-1829.
[10] Chen Z,Wang O,Nie M,et al.Aromatase deficiency in a Chinese adult man caused by novel compound
heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose
metabolism[J].Mol Cell Endocrinol,2015,399(9):32-42.
[11] 宋才淵,彭冰,沈佳怡,等.破骨細(xì)胞分化調(diào)節(jié)機(jī)制的研究進(jìn)展[J].中國骨傷,2015,28(6):580-584.
[12] 俞索靜,肖魯偉,吳承亮,等.破骨細(xì)胞血系起源的活細(xì)胞成像觀察[J].中國骨傷,2012,25(4):317-323.
中醫(yī)正骨2016年2月第28卷第2期 J Trad Chin Orthop Trauma,2016,Vol.28,No.2(總119)
(總120)中醫(yī)正骨2016年2月第28卷第2期 J Trad Chin Orthop Trauma,2016,Vol.28,No.2
[13] Brown JP,Dempster DW,Ding B,et al.Bone remodeling in postmenopausal women who discontinued denosumab
treatment: off-treatment biopsy study[J].J Bone Miner Res,2011,26(11):2737-2744.
[14] Rachner TD,Rauner M.RANKL/OPG in breast cancer - extending its territory to BRCA mutation carriers
[J].EBioMedicine,2015,2(10):1270-1271.
[15] Smith G,Stassen L,Flint S.Treating osteoporosis[J].Irish Medical Journal,2009,102(3):171-172.
[16] 黃立莉,洪文,王立源,等.絕經(jīng)后骨質(zhì)疏松癥的臨床治療進(jìn)展[J].中國醫(yī)藥導(dǎo)報,2011,8(18):7-10.
[17] Walsh MC,Kim N,Kadono Y,et al.Osteoimmunology:interplay between the immune system and bone metabolism
[J].Annu Rev Immunol,2006,24(1):33-63.
[18] 孫哲,林志勇,白廣亮,等.甲狀旁腺激素與雌激素對去勢雌性大鼠牙槽骨代謝的影響[J].華西口腔醫(yī)學(xué)雜志,2014,32
(2):134-137.
[19] Liang W,Lin M,Li X,et al.Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway
in the hFOB 1.19 human osteoblastic cell line[J].Int J Mol Med,2012,30(4):889-895.
[20] Bona H,Aroso M,Rinn C,et al.Analysis of low abundance membrane-associated proteins[J].Proteome
Res,2010,9(10):4927-4939.
[21] Xiang Q,Lin G,Fu X,et al.The role of peroxisome proliferator-activated receptor-gamma and estrogen
receptors in genistein-induced regulation of vascular tone in female rat aortas[J].Pharmacology,2010,86
(2):117-124.
[22] Sang C,Zhang Y,Chen F,et al.Tumor necrosis factor alpha suppresses osteogenic differentiation of MSCs by
inhibiting semaphorin 3B via Wnt/β-catenin signaling in estrogen-deficiency induced osteoporosis
[J].Bone,2015,84(6):78-87.
[23] 粱文娜,李燦東,李西海,等.絕經(jīng)后骨質(zhì)疏松癥中醫(yī)證素分布的臨床研究[J].福建中醫(yī)藥大學(xué)學(xué)報,2012,22(2):11-13.
[24] 梁文娜,李亞嬋,李西海,等.絕經(jīng)后骨質(zhì)疏松癥腎陽虛證證素變化與熵變的內(nèi)在關(guān)系[J].中華中醫(yī)藥雜志,2014,29
(6):1791-1793.
[25] Ma F,Gong F,Lv J,et al.Effects of a7nAChR agonist on the tissue estrogen receptor expression of castrated
rats[J].Int J Clin Exp Pathol,2015,8(10):13421-13425.
[26] Liao L,Su X,Yang X,et al.TNF-α inhibits FoxO1 by up-regulating MiR-705 to aggravate oxidative damage in
bone Marrow-Derived mesenchymal stem cells during osteoporosis[J].Stem Cells,2015,5(10):1002-1004.
[27] Bertonazzi A,Nelson B,Salvador J,et al.The smallest available estradiol transdermal patch:a new treatment
option for the prevention of postmenopausal osteoporosis[J].Womens Health(Lond Engl),2015,11(6):815-824.
[28] Tseng SH,Chen LG,Lai YJ,et al.Effects of different forages on the chemical compositions and
antiosteoporotic activities of velvet antlers[J].Animal Science Journal,2015,10(6):1111-1120.
[29] Kovacic N,Grcevic D,Katavic V,et al.Fas receptor is required for estrogen deficiency-induced bone loss in
mice[J].Lab Invest,2010,90(3):402-413.
[30] Syed FA,Fraser DG,Monroe DG,et al.Distinct effects of loss of classical estrogen receptor signaling
versus complete deletion of estrogen receptor alpha on bone[J].Bone,2011,49(2):208-216.
[31] Widschwendter M,Burnell M,Fraser L,et al.Osteoprotegerin(OPG),the endogenous inhibitor of receptor
activator of NF-κB ligand(RANKL),is dysregulated in BRCA mutation carriers[J].EBioMedicine,2015,2(10):1331-
1339.
[32] Cervellati C,Romani A,Cremonini E,et al.Higher urinary levels of 8-Hydroxy-2'-deoxyguanosine are
associated with a worse RANKL/OPG ratio in postmenopausal women with osteopenia[J].Oxid Med Cell Longev,2016,
(9):6038.
[33] 薛昊罡,冷冰,馬恩元,等.雌激素水平與絕經(jīng)女性并發(fā)骨質(zhì)疏松癥的相關(guān)性研究[J].中國婦幼保健,2011,26(26):4106-
4108.
[34] Zheng X,Lee SK,Chun OK.Soy isoflavones and osteoporotic bone loss:a review with an emphasis on modulation
of bone remodeling[J].J Med Food,2016,19(1):1-14.
[35] 李雪峰,李冠武,常時新,等.MRI水/脂分離技術(shù)評價雌激素對骨質(zhì)疏松骨髓脂肪的作用[J].實用放射學(xué)雜志,2015,31
(3):480-483.
[36] Gobek K,Ostrowska Z,Ziora K,et al.Association between omentin-1,bone metabolism markers,and cytokines
of the RANKL/RANK/OPG system in girls with anorexia nervosa[J].Endokrynol Pol,2015,66(6):514-520.
[37] 馬培奇.絕經(jīng)后婦女骨質(zhì)疏松癥防治用選擇性雌激素受體調(diào)節(jié)劑研究進(jìn)展[J].中國制藥信息,2015,31(7):10-13.
[38] 李聯(lián)祥,王黎光,申育華,等.正常及異常組織中雌激素α及β受體的表達(dá)[J].中國組織工程研究與臨床康復(fù),2010,14
(50):9442-9446.
[39] 王嘯,劉祿林,沈光思,等.雌激素下降合并鐵蓄積對骨組織骨量影響的實驗研究[J].中華骨科雜志,2015,35(10):1011-
1016.
[40] Yoldemir T,Erenus M,Durmusoglu F.The impact of serum FSH and estradiol on postmenopausal osteoporosis
related to time since menopause[J].Gynecol Endocrinol,2012,28(11):884-888.
[41] 王亞春,孫紹騫,王銳,等.雌激素和骨標(biāo)志物與絕經(jīng)后婦女骨質(zhì)疏松的關(guān)系[J].中國婦幼保健,2015,30(27):4675-4676.
[42] Trombelli L,Penolazzi L,Torreggiani E,et al.Effect of hydroxyapatite-based biomaterials on human
osteoblast phenotype[J].Minerva Stomatol,2010,59(3):103-115.
[43] Saha H,Mukherjee B,Bindhani B,et al.Changes in RANKL and osteoprotegerin expression after chronic
exposure to indoor air pollution as a result of cooking with biomass fuel[J].J Appl Toxicol,2015,22(2):297-
301.
[44] Bougioukli S,Jain A,Sugiyama O,et al.Combination therapy with BMP-2 and a systemic RANKL inhibitor
enhances bone healing in a mouse critical-sized femoral defect[J].Bone,2015,84(2):93-103.
[45] Yu XJ,Xiao CJ,Du YM,et al.Effect of hypoxia on the expression of RANKL/OPG in human periodontal ligament
cells in vitro[J].Int J Clin Exp Pathol,2015,8(10):12929-12935.
相似文獻(xiàn)/References:
[1]劉磊,萬春友,全先輝,等.鎖定鋼板內(nèi)固定結(jié)合肱骨頭植骨重建治療
肱骨近端Neer三、四部分骨折[J].中醫(yī)正骨,2015,27(10):52.
[2]徐偉鋒,葉健,吳連國.強(qiáng)骨飲對骨質(zhì)疏松性股骨頸骨折患者全髖關(guān)節(jié)置換術(shù)后
血清骨代謝生化指標(biāo)和骨密度的影響[J].中醫(yī)正骨,2015,27(02):12.
XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(強(qiáng)骨飲,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):12.
[3]龔江浩.股骨近端防旋髓內(nèi)釘聯(lián)合抗骨質(zhì)疏松藥物治療
不穩(wěn)定型老年股骨轉(zhuǎn)子間骨折的臨床觀察[J].中醫(yī)正骨,2015,27(04):29.
GONG Jianghao.A combination therapy of proximal femoral nail antirotation and anti-osteoporotic drugs for the treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):29.
[4]費國芳,費紅良,王金法.兩種內(nèi)固定方法治療老年不穩(wěn)定性股骨轉(zhuǎn)子間骨折的對比研究[J].中醫(yī)正骨,2016,28(05):9.
FEI Guofang,FEI Hongliang,WANG Jinfa.Comparison of two kinds of internal fixation for treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):9.
[5]陳思凱,邢金明.骨水泥強(qiáng)化椎弓根螺釘內(nèi)固定治療老年胸腰椎壓縮性骨折[J].中醫(yī)正骨,2016,28(05):35.
[6]孫鵬,譚磊,閻乾,等.人工肱骨頭置換術(shù)治療老年肱骨近端Neer三、四部分骨折[J].中醫(yī)正骨,2016,28(05):43.
[7]王博,吳鵬,史曉林.強(qiáng)骨飲對去卵巢骨質(zhì)疏松大鼠骨顯微結(jié)構(gòu)的影響[J].中醫(yī)正骨,2016,28(07):6.
WANG Bo,WU Peng,SHI Xiaolin.A retrospective trial of postural reduction combined with percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):6.
[8]馮建軍,鄒浩,朱海燕,等.槲皮素對去卵巢大鼠血清骨鈣素和股骨Ⅰ型膠原蛋白水平的影響[J].中醫(yī)正骨,2016,28(07):10.
FENG Jianjun,ZOU Hao,ZHU Haiyan,et al.Leverage bone grafting and pedicle screw internal fixation through posterior approach for treatment of thoracolumbar fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):10.
[9]王吉利,萬雷,張志海,等.抑制Dickkopf-1和Sclerostin表達(dá)對人成骨肉瘤細(xì)胞MG63骨代謝調(diào)節(jié)相關(guān)蛋白表達(dá)水平的影響[J].中醫(yī)正骨,2016,28(09):13.
WANG Jili,WAN Lei,ZHANG Zhihai,et al.Effect of suppression of Dickkopf-1 and Sclerostin expression on bone metabolism regulatory protein expression levels in human osteosarcoma MG63 cells[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):13.
[10]張國文.肱骨近端鎖定接骨板內(nèi)固定治療肱骨近端骨折[J].中醫(yī)正骨,2016,28(08):50.